The treatment of neuroblastoma is based on the child’s age; the size, location and biologic features of the tumor; and whether the cancer has spread. Generally, treatments include chemotherapy, surgery, and/or radiation therapy. Combinations of two or three of these treatments may be used for some children.
Other types of treatments are being tested in clinical trials. Some children will require a combination of treatments, including intensive chemotherapy and a bone marrow transplant.
If the cancer continues to grow during treatment, it is called progressive neuroblastoma. Recurrent neuroblastoma is when the cancer comes back after treatment, either to the same or different location. The Children’s Cancer Hospital has many new treatment trials available and in development for the specific treatment of progressive and recurrent neuroblastomas.
If your child has been diagnosed with neuroblastoma, we’re here to help. Call 1-877-MDA-6789 to make an appointment or request an appointment online.
Our Neuroblastoma Clinical Trials
The most innovative treatments for childhood central nervous system tumors are offered as part of clinical trials, which are closely monitored studies to test the safety and effectiveness of new treatments. Go to MD Anderson's list of current pediatric clinical trials to see if your child might be eligible.
You can also visit our Clinical Trials database or speak to your doctor.
Why Choose MD Anderson?
- The Children’s Cancer Hospital is within the No. 1 cancer center in America
- Access to novel therapies and state-of-the-art technologies before most children’s hospitals
- We see more types of cancer than any other children’s hospital in Texas
- Family-centered care that actively involves parents in their child’s treatment
- A strong cancer research program focused on developing new therapies for pediatric patients
- Comprehensive support services such as an accredited school program, creative arts, child life and career counseling
- An Adolescent and Young Adult Program that specializes in the unique medical and psychological needs of patients aged 15-25